What is Cupron?
Cupron is at the forefront of developing and applying copper-based antimicrobial technologies. The company embeds specified copper compounds within polymers, creating finished products designed for healthcare, consumer goods, industrial applications, and military use. Unlike superficial treatments, Cupron's embedded copper technology is durable and does not degrade over time through washing or rubbing, offering a long-lasting antimicrobial solution. This unique integration of copper compounds into materials provides a robust defense against microbial growth.
How much funding has Cupron raised?
Cupron has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Cupron?
With its substantial late-stage funding, Cupron is strategically positioned for accelerated growth and market expansion. The company's focus on durable, embedded copper antimicrobial solutions suggests a trajectory towards scaling production and broadening its application portfolio. Future developments are likely to involve deeper penetration into healthcare settings, enhanced consumer product integration, and potentially new industrial and defense contracts. This capital infusion will be critical for R&D, manufacturing capacity, and global market outreach, solidifying Cupron's position as a leader in advanced antimicrobial materials.
See full Cupron company page
